[Levofloxacin (Tavanic) in complex therapy of tuberculosis].
Antibiot Khimioter
; 54(1-2): 31-7, 2009.
Article
en Ru
| MEDLINE
| ID: mdl-19499715
ABSTRACT
Preclinical and clinical investigations of levofloxacin in complex with antituberculosis drugs of the main and reserve groups in 152 patients with newly diagnosticated drug resistant pulmonary tuberculosis demonstrated its efficacy and safety. The adverse events due to levofloxacin (8.6% of the cases) disappeared after discontinuation of the drug use without any affection of the patient's organs. Levofloxacin is applicable in antituberculosis therapy of patients with extended, acute progressing or polycavernous tuberculosis of the lungs. It provides significant clinical improvement and if necessary allows to prepare the patient in a short period for surgical operation.
Buscar en Google
Bases de datos:
MEDLINE
Métodos Terapéuticos y Terapias MTCI:
Plantas_medicinales
Asunto principal:
Tuberculosis Pulmonar
/
Ofloxacino
/
Levofloxacino
/
Mycobacterium tuberculosis
/
Antituberculosos
Tipo de estudio:
Diagnostic_studies
Idioma:
Ru
Revista:
Antibiot Khimioter
Año:
2009
Tipo del documento:
Article